BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24075399)

  • 1. Opioid pharmacotherapy: Treatment, regimes, constructions and control.
    Neale J
    Int J Drug Policy; 2013 Nov; 24(6):e1-5. PubMed ID: 24075399
    [No Abstract]   [Full Text] [Related]  

  • 2. The politics of providing opioid pharmacotherapy.
    Radcliffe P; Parkes T
    Int J Drug Policy; 2013 Nov; 24(6):e6-10. PubMed ID: 24183331
    [No Abstract]   [Full Text] [Related]  

  • 3. Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the "small stuff" in a liberal paradise.
    Treloar C; Valentine K
    Int J Drug Policy; 2013 Nov; 24(6):e11-3. PubMed ID: 23711673
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.
    Schmidt CS; Schulte B; Wickert C; Thane K; Kuhn S; Verthein U; Reimer J
    Int J Drug Policy; 2013 Nov; 24(6):e111-4. PubMed ID: 23726899
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of the Chinese police in methadone maintenance therapy: a literature review.
    Meng J; Burris S
    Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic.
    Crawford S
    Int J Drug Policy; 2013 Nov; 24(6):e14-7. PubMed ID: 24007689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine implants (Probuphine) for opioid dependence.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):94-5. PubMed ID: 27403784
    [No Abstract]   [Full Text] [Related]  

  • 8. Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.
    Med Lett Drugs Ther; 2018 Feb; 60(1541):35-37. PubMed ID: 29485976
    [No Abstract]   [Full Text] [Related]  

  • 9. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
    Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
    Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
    Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
    Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The marketing of methadone: how an effective medication became unpopular.
    Bruce RD
    Int J Drug Policy; 2013 Nov; 24(6):e89-90. PubMed ID: 24246504
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs for opioid Use disorder.
    Med Lett Drugs Ther; 2017 Jun; 59(1522):89-95. PubMed ID: 28609420
    [No Abstract]   [Full Text] [Related]  

  • 13. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing access to opioid maintenance treatment: the role of primary care in France.
    Roux P; Lions C; Carrieri MP
    Int J Drug Policy; 2015 Apr; 26(4):434-5. PubMed ID: 25683137
    [No Abstract]   [Full Text] [Related]  

  • 15. Categorising methadone: Addiction and analgesia.
    Keane H
    Int J Drug Policy; 2013 Nov; 24(6):e18-24. PubMed ID: 23768774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
    Horyniak D; Dietze P; Larance B; Winstock A; Degenhardt L
    Int J Drug Policy; 2011 Mar; 22(2):167-71. PubMed ID: 21112758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison table: some drugs for maintenance treatment of opioid use disorder.
    Med Lett Drugs Ther; 2017 May; 59(1521):e96-e97. PubMed ID: 28609422
    [No Abstract]   [Full Text] [Related]  

  • 18. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

  • 19. Methadone, a contested substance: Danish methadone policy in the 1970s.
    Houborg E
    Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At least 80 people have died in Crimea since Russian law banned opioid substitutes, says UN special envoy.
    Hurley R
    BMJ; 2015 Jan; 350():h390. PubMed ID: 25608514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.